-
Mashup Score: 0Renal Amyloidosis: Presentation, Diagnosis, and Management - 3 year(s) ago
More than 35 amyloid precursor proteins have been identified and many have tropism for the kidney. Renal amyloidosis is most commonly seen in AL and AA amyloidosis and the main clinical manifestations are proteinuria and progressive renal dysfunction. On renal pathology, hallmark findings of amyloidosis include Congo red positivity with apple-green birefringence and randomly arranged fibrils…
Source: The American Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Developing Therapy for Transthyretin Amyloidosis - 3 year(s) ago
Transthyretin amyloidosis (ATTR) is an under-recognized cause of cardiomyopathy and neuropathy. Until recently, there were limited therapeutic options for ATTR. However, new therapeutics including tafamidis, patisiran, and inotersen increase both quality and length of life of patients with ATTR. This review details the chronological development of ATTR therapies through landmark clinical trials….
Source: The American Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
"Developing Therapy for ATTR #Amyloidosis" by Drs. Courtney Campbell (me!), Katie Zhang, Dan Lenihan, & Ron Witteles @Ron_Witteles -Available therapies for ATTR 💊 -Data✍️ for stabilizers & silencers -Ongoing clinical trials for ATTR ❤️🧠 https://t.co/f9PtV5fglJ 9/11 https://t.co/DTuJOXSPgr
-
-
Mashup Score: 0COVID-19 and Light Chain Amyloidosis, Adding Insult To Injury - 3 year(s) ago
Light chain amyloidosis (AL) is a potentially fatal disease of monoclonal plasma cells which leads to accumulation of light chain amyloid fibrils, organ damage and the manifestations of clinical disease. Meanwhile, COVID-19 is a disease caused by infection with the SARS-CoV-2 virus, with the potential to cause severe systemic illness and death. There is significant overlap in the demographics and…
Source: The American Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
"COVID-19 & Light Chain #Amyloidosis: Adding Insult to Injury" by Drs. Zachary Crees & Keith Stockerl-Goldstein @CyclingDoctor -Optimize Treatment 💊 -Mitigate Risk 😷📞 -Vaccination Considerations💉 https://t.co/yZ8p41Iu0h 10/11 https://t.co/6Q4WhzN55L
-
-
Mashup Score: 0Future Developments in Light Chain Amyloidosis Management - 3 year(s) ago
AL amyloidosis is challenging to diagnose and it should be considered a cardiac emergency. There has been a great deal of advances in the treatment of AL amyloidosis from initial descriptions of melphalan therapy until the recent approval of the first AL amyloidosis specific drug (daratumumab). Comprehension of the pathophysiology and biology of AL amyloidosis is key to understand the major…
Source: The American Journal of MedicineCategories: Cardiologists, Latest HeadlinesTweet-
"Future Developments 🔬 in Light Chain #Amyloidosis Management" by Drs. Mario Rodriguez @wustlcardfellow, Dan Lenihan, & Giampaolo Merlini @gmerlini -Alkylators -Monoclonal abs -Proteosome inhibitors -Immunomodulators -Protein stabilizers https://t.co/ogZErs0hZm 11/11 Fin! https://t.co/HsZojXg68D
-
-
Mashup Score: 0Fellowship Programs - American College of Cardiology - 3 year(s) ago
Are you interested in finding a Cardio-Oncology training program or fellowship? Browse our current list to see what’s available.
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
If you are a #ACCFIT considering additional training in cardio-oncology, learn about fellowships here: https://t.co/Pp8wheouFG Invaluable clinical experience PLUS you can incorporate advanced training in basic or clinical research, cardiac imaging, or whatever fits your goals! https://t.co/fSjvmc2AWY
-
-
Mashup Score: 7
A list of the Cardio-Oncology Section’s Section Work Groups
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
Inspired by @ACCinTouch's Advancing Cardiovascular Care of the Oncology Patient? Join the Cardio-Oncology section and get involved in our section work groups: https://t.co/6BAD0Qi66a I'm proud to rep #ACCFIT interests on amazing #cardioonc council: https://t.co/aiJXd72IO5 https://t.co/MjRjvDG0y4
-
-
Mashup Score: 4
Did you know that 47% of American adults – nearly 1 in 2 – have high blood pressure? Many people don’t even know they have high blood pressure (also called hypertension). That’s because there are often no warning signs. But having high blood pressure makes a stroke or heart attack much more likely.Why? High blood pressure is the force of your blood moving against the walls of…
Source: CardioSmartCategories: Cardiologists, Latest HeadlinesTweet-
Masterclass in management of #Hypertension in #CardioOnc at @ACCinTouch's CV Care of Onc Patient. The fantastic @KerrySkurka shares practical pearls to ensure accurate BP measurements. Also check out: https://t.co/49sVCWjd6Z #MedTwitter #CardioTwitter https://t.co/678ENPy5QR
-
-
Mashup Score: 1Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS - 3 year(s) ago
Because patients with ATTRv cardiomyopathy are more likely to be male, this analysis aimed to increase information on associations between sex and gen…
Source: www.sciencedirect.comCategories: Cardiologists, Latest HeadlinesTweet-
Excellent @JACCJournals #JACCHF #amyloidosis paper by @agcaponetti looking at sex differences in cardiac involvement of hereditary/variant ATTR from the THAOS registry. #cardiotwitter #cardioonc https://t.co/ciyc7x3vFT https://t.co/OivAxLmUzF
-
-
Mashup Score: 22Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy - 3 year(s) ago
AbstractAims. Cardiac immune-related adverse events (irAEs) from immune checkpoint inhibition (ICI) targeting programmed death 1 (PD1) are of growing concern. O
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
RT @TRassafMD: Just published in #EuropeanHeartJournal https://t.co/noptjBqHAO Anti-PD1 immune checkpoint inhibitor therapy induces an i…
-
-
Mashup Score: 7Advancing the Cardiovascular Care of the Oncology Patient Virtual - American College of Cardiology - 4 year(s) ago
Access until April 25, 2021 Learn how to access the site, use the live chat features, and claim credits. Join Course Directors Ana Barac, MD, PhD, FACC and Bonnie Ky, MD, MSCE, FACC for Advancing the Cardiovascular Care of the Oncology Patient Virtual! Register and gain access to: Live educational sessions with real-time discussion opportunities…
Source: American College of CardiologyCategories: Cardiologists, Latest HeadlinesTweet-
Excited for @ACCinTouch's Virtual #CardioOnc ♥️ Conference w Q&A Fri 2/5 & talks Sat 2/6! Last year's conference introduced me to the amazing #CardioOnc🥰community & crystalized the direction of my career. Register: https://t.co/O5ayqIzsrM https://t.co/72x3P8hQgG
-
"Renal #Amyloidosis: Presentation, Diagnosis, & Management" By Drs. Reena Gurung & Tingting Li @Ting2li @WUNephrology -Subtypes with renal involvement -Proteinuria & renal dysfunction -Supportive management 🧂💊 -HD/Transplant considerations 🏥 https://t.co/iUnHOx1inI 8/11 https://t.co/7o7v5KFaxQ